| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 132,924 | 132,178 | 130,285 | 123,947 | | Cost of Revenue | 110,971 | 109,014 | 107,900 | 102,081 | | | Gross Profit | 21,953 | 23,164 | 22,385 | 21,866 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,883 | 5,417 | 4,961 | 5,389 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 3,239 | 3,209 | 2,965 | 2,513 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 13,831 | 14,538 | 14,459 | 13,964 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 81 | 69 | 70 | 280 | | Earnings Before Interest And Taxes | 13,912 | 14,607 | 14,529 | 14,244 | | Interest Expense | 1,249 | 1,141 | 1,328 | 1,231 | | Income Before Tax | 12,663 | 13,466 | 13,201 | 13,013 | | Income Tax Expense | 4,977 | 5,282 | 5,278 | 5,154 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 7,686 | 8,184 | 7,923 | 7,859 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 7,686 | 8,184 | 7,923 | 7,859 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $7,686 | $8,184 | $7,923 | $7,859 |
|
0.11% Nasdaq 0.00%
Income Statement
